Health Canada approve Remora™ technology in two medical devices.

Health Canada approve Remora™ technology in two medical devices.

News

Unilever and Innova Partnerships one step closer to
self-cleaning surfaces

Working with our dental partners Pro3dure Medical, our anti biofilm platform (Remora™) has been incorporated into two of their key medical devices using their MSI® (Multi Species Inhibition) technology. We are delighted to announce that Health Canada have now reviewed and granted licenses for these medical devices. This is a great milestone for Penrhos Bio and further indication of the confidence in the Remora technology.

Congratulations to our partners in Pro3dure and to our licence partner and Key Opinion Leader in the dental space Dr Gary Jernberg, who has been instrumental in this partnership.

Penrhos Bio Launch Series A raise

Penrhos Bio is currently undertaking a Series A investment raise. This investment will accelerate our regulatory roadmap for the Remora™ technology and unlocks a number of higher value markets such as marine fouling and human healthcare…

Read More »